Drug evaluation: CP-751871, a human antibody against type I insulin-like growth factor receptor for the potential treatment of cancer. [electronic resource]
- Current opinion in molecular therapeutics Jun 2007
- 299-304 p. digital
Publication Type: Journal Article
1464-8431
Antibodies--adverse effects Carboplatin--therapeutic use Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Drug Evaluation, Preclinical Humans Neoplasms--drug therapy Paclitaxel--therapeutic use Receptors, Somatomedin--immunology